The trial will evaluate the safety and effectiveness of a next-generation vaccine administered through a nasal spray or ...
More than one million older people in England will be invited to get vaccines for respiratory syncytial virus (RSV), with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback